鲁米诺单钠盐结构式
|
常用名 | 鲁米诺单钠盐 | 英文名 | LUMINOL SODIUM SALT |
---|---|---|---|---|
CAS号 | 20666-12-0 | 分子量 | 200.15 | |
密度 | 1.433g/cm3 | 沸点 | 621.9ºC at 760mmHg | |
分子式 | C8H7N3NaO2+ | 熔点 | 319-320ºC | |
MSDS | 中文版 美版 | 闪点 | 329.9ºC | |
符号 |
GHS07 |
信号词 | Warning |
鲁米诺单钠盐用途Luminol(Diogenes reagent)是化学发光试剂,与一定的氧化剂反应时能发出蓝光。 |
中文名 | 鲁米诺单钠盐 |
---|---|
英文名 | 3-aminophthalhydrazide monosodium salt |
中文别名 | 3-氨基邻苯二甲酰肼一钠盐 | 鲁米诺钠盐 |
英文别名 | 更多 |
密度 | 1.433g/cm3 |
---|---|
沸点 | 621.9ºC at 760mmHg |
熔点 | 319-320ºC |
分子式 | C8H7N3NaO2+ |
分子量 | 200.15 |
闪点 | 329.9ºC |
PSA | 88.84000 |
LogP | 0.00890 |
外观性状 | 白色到浅绿色 粉末 |
储存条件 | 保持贮藏器密封 放入紧密的贮藏器内,储存在阴凉,干燥的地方 |
稳定性 | 如果遵照规格使用和储存则不会分解 避免接触酸,氧化物,还原剂,碱 |
更多 | 1.性状:白色粉末 2.密度(g/mL,25/4℃):未确定 3.相对蒸汽密度(g/mL,空气=1):未确定 4.熔点(ºC):>300 5.沸点(ºC,常压):未确定 6.沸点(ºC,5.2kPa):未确定 7.折射率:未确定 8.闪点(ºC):未确定 9.比旋光度(º):未确定 10.自燃点或引燃温度(ºC):未确定 11.蒸气压(kPa,25ºC):未确定 12.饱和蒸气压(kPa,60ºC):未确定 13.燃烧热(KJ/mol):未确定 14.临界温度(ºC):未确定 15.临界压力(KPa):未确定 16.油水(辛醇/水)分配系数的对数值:未确定 17.爆炸上限(%,V/V):未确定 18.爆炸下限(%,V/V):未确定 19.溶解性:未确定 |
符号 |
GHS07 |
---|---|
信号词 | Warning |
危害声明 | H315-H319-H335 |
警示性声明 | P261-P305 + P351 + P338 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xi: Irritant; |
风险声明 (欧洲) | R36/37/38 |
安全声明 (欧洲) | S26-S36 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
海关编码 | 2933990090 |
海关编码 | 2933990090 |
---|---|
中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Assessment of the translational value of mouse lupus models using clinically relevant biomarkers
Transl. Res. 163(6) , 515-32, (2014) Lupus is an autoimmune disease with a poorly understood etiology that manifests with a diverse pathology. This heterogeneity has been a challenge to clinical drug development efforts. A related diffic... |
|
Oral treatment with the herbal formula B307 alleviates cardiac toxicity in doxorubicin-treated mice via suppressing oxidative stress, inflammation, and apoptosis.
Onco. Targets Ther. 8 , 1193-210, (2015) This study aimed to investigate whether the herbal formula B307 could alleviate doxorubicin (DOX)-induced acute cardiotoxicity. If so, we further unraveled possible molecular mechanisms of cardiac pro... |
|
Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst.
J. Neuroimmunol. 276(1-2) , 71-9, (2014) Neuroinflammation contributes to the pathogenesis of neurological disorders. Anti-inflammatory treatments could potentially be used to slow down the progression of these diseases. We studied the anti-... |
5-Amino-2,3-dihydrophthalazine-1,4-dione,sodium salt |
Natrium-3-amino-phthalhydrazid |
3-Aminophthalhydrazide,5-Amino-2,3-dihydro-1,4-phthalazinedione |
LUMINOL SODIUM SALT HG |
3-Aminophthalhydrazide monosodium salt |
5-Amino-2,3-dihydro-phthalazin-1,4-dion,Natrium-Salz |
Tamirite |
Luminol sodium salt |
5-amino-2,3-dihydro-phthalazine-1,4-dione,sodium-salt |
3-AMINOPHTHALHYDRAZIDE SODIUM SALT |
Galavit |
1,4-Phthalazinedione, 5-amino-2,3-dihydro-, sodium salt (1:1) |
MFCD00161491 |
Luminol Mono Sodium Salt |
Tamerit |
Luminol (sodium salt) |
3-AMinophthalhydrazide sodiuM |
Sodium 5-amino-4-oxo-3,4-dihydro-1-phthalazinolate |
SODIUM LUMINOL |